Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: The Fragility of Metaphors (FraMe): Learning, Loosing, and How to Train Them
A clinical trial update from IRCCS San Raffaele indicating the FraMe study for schizophrenia and psychosis is currently enrolling by invitat…
-
FDA approval · 2025-01-23FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) from Janssen Pharmaceuticals, Inc. The action updates o…
-
FDA approval · 2025-01-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for Lannett's generic aripiprazole, authorizing a generic formulation of the antipsychotic.
-
FDA approval · 2025-01-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application to authorize a new orally disintegrating tablet formulation of aripiprazole from Dr. Reddy's Laborat…
-
FDA approval · 2025-01-23FDA Approved: RISPERIDONE — Supplemental Application (Amici Pharma, Inc.)
FDA approved a supplemental application for risperidone from Amici Pharma, Inc., updating the drug's labeling and/or indications. This actio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Minnesota Community-Based Cognitive Training in Early Psychosis [NA]
Update on the completed clinical trial of Minnesota's community-based cognitive training for people with early psychosis; results have been …
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: The Effects of Psyllium Seed on Body Weight and Metabolic Syndrome Indicators in Patients with Schizophrenia [NA]
A completed clinical trial evaluated the effects of psyllium seed on body weight and metabolic syndrome indicators in overweight or obese pa…
-
FDA approval · 2025-01-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Advagen Pharma Ltd)
FDA approved Advagen Pharma Ltd's supplemental application for aripiprazole (ARIPIPRAZOLE) under ANDA216351.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Apathy in Schizophrenia
INSERM-sponsored clinical trial studying apathy in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Improving Real-world Function for Persons with Schizophrenia: a Single-case Experimental Design [NA]
This clinical trial update describes a single-case experimental design study aimed at improving real-world functioning in people with schizo…
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves a supplemental application for Fluphenazine hydrochloride from Alembic Pharmaceuticals Limited.
-
FDA approval · 2025-01-22FDA Approved: ERZOFRI EXTENDED-RELEASE — Supplemental Application (Shandong Luye Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for ERZOFRI EXTENDED-RELEASE (paliperidone palmitate) from Shandong Luye Pharmaceutical Co., Ltd.
-
FDA label_change · 2025-01-22FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
The FDA approved a supplemental application for CLOZARIL (clozapine) submitted by HLS Therapeutics USA, Inc., resulting in an update to the …
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Haloperidol lactate from Fresenius Kabi USA, LLC.
-
FDA approval · 2025-01-22FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride by Sandoz Inc., authorizing its generic formulation.
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
The FDA approved a supplemental application for haloperidol decanoate from Patriot Pharmaceuticals LLC, a long-acting antipsychotic.
-
FDA label_change · 2025-01-22FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for ZYPREXA INTRAMUSCULAR (olanzapine) from Eli Lilly and Company, updating the labeling to include …
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (Innogenix, Inc.)
FDA approved a supplemental application for HALOPERIDOL submitted by Innogenix, Inc., marking an approved update to the product through a su…
-
FDA approval · 2025-01-22FDA Approved: ARISTADA INITIO — Supplemental Application (Alkermes, Inc.)
The FDA approved a supplemental application for ARISTADA INITIO, providing a loading-dose formulation of aripiprazole lauroxil for initiatin…
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for Fluphenazine hydrochloride by PAI Holdings (PAI Pharma), updating the status of this generic pro…
-
FDA approval · 2025-01-22FDA Approved: PERPHENAZINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for PERPHENAZINE (perphenazine) submitted by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceutical…
-
FDA label_change · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
This document records Upsher-Smith's supplemental application for labeling changes to Fluphenazine hydrochloride.
-
FDA approval · 2025-01-22FDA Approved: RISPERIDONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for risperidone from Sun Pharmaceutical Industries, Inc., indicating an update to labeling or indica…
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Fluphenazine hydrochloride from Aurobindo Pharma Limited.
-
FDA approval · 2025-01-22FDA Approved: THIOTHIXENE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for thiothixene from Amneal Pharmaceuticals NY LLC.